188 related articles for article (PubMed ID: 11469515)
1. The treatment of Sjögren's syndrome patients with pilocarpine-tablets.
Vivino FB
Scand J Rheumatol Suppl; 2001; 115():1-9; discussion 9-13. PubMed ID: 11469515
[TBL] [Abstract][Full Text] [Related]
2. [Treatment with pilocarpine hydrochloride for sicca symptoms in Sjögren's syndrome].
Takaya M; Ichikawa Y; Yamada C; Hoshina Y; Horiki T; Uchiyama M
Ryumachi; 1997 Jun; 37(3):453-7. PubMed ID: 9256028
[TBL] [Abstract][Full Text] [Related]
3. The use of oral pilocarpine in xerostomia and Sjögren's syndrome.
Nusair S; Rubinow A
Semin Arthritis Rheum; 1999 Jun; 28(6):360-7. PubMed ID: 10406404
[TBL] [Abstract][Full Text] [Related]
4. Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjögren's syndrome. The MGI PHARMA Sjögren's Syndrome Study Group.
Nelson JD; Friedlaender M; Yeatts RP; Yee R; McDermott M; Orlin S; Gallagher SC; Shrotriya RC
Adv Exp Med Biol; 1998; 438():979-83. PubMed ID: 9634998
[No Abstract] [Full Text] [Related]
5. Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial.
Cifuentes M; Del Barrio-Díaz P; Vera-Kellet C
Br J Dermatol; 2018 Nov; 179(5):1056-1061. PubMed ID: 29432648
[TBL] [Abstract][Full Text] [Related]
6. Effect of Pilocarpine on impaired salivary secretion in patients with Sjögren's syndrome.
Jorkjend L; Bergenholtz A; Johansson AK; Johansson A
Swed Dent J; 2008; 32(2):49-56. PubMed ID: 18700333
[TBL] [Abstract][Full Text] [Related]
7. Oral pilocarpine HCl stimulates labial (minor) salivary gland flow in patients with Sjögren's syndrome.
Rhodus NL
Oral Dis; 1997 Jun; 3(2):93-8. PubMed ID: 9467349
[TBL] [Abstract][Full Text] [Related]
8. Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.
Al-Hashimi I
Drugs Aging; 2005; 22(11):887-99. PubMed ID: 16323968
[TBL] [Abstract][Full Text] [Related]
9. [Pilocarpus in Sjogren's syndrome].
Drøsdal HH
Tidsskr Nor Laegeforen; 2003 Jan; 123(1):82-3. PubMed ID: 12600163
[No Abstract] [Full Text] [Related]
10. Pilocarpine toxicity and the treatment of xerostomia.
Hendrickson RG; Morocco AP; Greenberg MI
J Emerg Med; 2004 May; 26(4):429-32. PubMed ID: 15093850
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of oral pilocarpin therapy in the treatment of xerostomia and xerophthalmia in patients with primary Sjögren's syndrome].
Solans R; Bosch JA; Selva A; Simeón CP; Fonollosa V; Vilardell M
Med Clin (Barc); 2004 Feb; 122(7):253-5. PubMed ID: 15012873
[TBL] [Abstract][Full Text] [Related]
12. Salivary gland ultrasonography as a primary imaging tool for predicting efficacy of xerostomia treatment in patients with Sjögren's syndrome.
Takagi Y; Sumi M; Nakamura H; Sato S; Kawakami A; Nakamura T
Rheumatology (Oxford); 2016 Feb; 55(2):237-45. PubMed ID: 26338664
[TBL] [Abstract][Full Text] [Related]
13. Conjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndrome.
Aragona P; Di Pietro R; Spinella R; Mobrici M
Br J Ophthalmol; 2006 Feb; 90(2):166-70. PubMed ID: 16424527
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of orally administered pilocarpine hydrochloride for patients with juvenile-onset Sjögren's syndrome.
Tomiita M; Takei S; Kuwada N; Nonaka Y; Saito K; Shimojo N; Kohno Y
Mod Rheumatol; 2010 Oct; 20(5):486-90. PubMed ID: 20517630
[TBL] [Abstract][Full Text] [Related]
15. The therapy of Sjogren's syndrome: a review.
Coaccioli S; Giuliani M; Puxeddu A
Clin Ter; 2007; 158(5):453-6. PubMed ID: 18062353
[TBL] [Abstract][Full Text] [Related]
16. Pilocarpine hydrochloride for the treatment of xerostomia in patients with Sjögren's syndrome in Taiwan--a double-blind, placebo-controlled trial.
Wu CH; Hsieh SC; Lee KL; Li KJ; Lu MC; Yu CL
J Formos Med Assoc; 2006 Oct; 105(10):796-803. PubMed ID: 17000452
[TBL] [Abstract][Full Text] [Related]
17. Use of muscarinic agonists in the treatment of Sjögren's syndrome.
Fox RI; Konttinen Y; Fisher A
Clin Immunol; 2001 Dec; 101(3):249-63. PubMed ID: 11726216
[TBL] [Abstract][Full Text] [Related]
18. [Results of the treatment with oral pilocarpine in 100 patients with primary Sjögrens syndrome].
Brito-Zerón P; Ramos-Casals M; Nardi N; Font J
Med Clin (Barc); 2006 Apr; 126(16):637. PubMed ID: 16759558
[No Abstract] [Full Text] [Related]
19. Comparison of the discontinuation rates and side-effect profiles of pilocarpine and cevimeline for xerostomia in primary Sjögren's syndrome.
Noaiseh G; Baker JF; Vivino FB
Clin Exp Rheumatol; 2014; 32(4):575-7. PubMed ID: 25065774
[TBL] [Abstract][Full Text] [Related]
20. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group.
Vivino FB; Al-Hashimi I; Khan Z; LeVeque FG; Salisbury PL; Tran-Johnson TK; Muscoplat CC; Trivedi M; Goldlust B; Gallagher SC
Arch Intern Med; 1999 Jan; 159(2):174-81. PubMed ID: 9927101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
